Pregnancy test: Clinical Trials

5 trials of Pregnancy test, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 recruiting, 1 terminated. 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 25Completed 2, Recruiting 2, Terminated 1

Follow Pregnancy test: new trials by email Literature Review of Pregnancy test trials Research Report on Pregnancy test

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trial for Local Ablative Treatment (LAT) Optimization in Patients With Advanced Non-Small Cells Lung Cancer (NSCLC) Presenting an Anaplastic Lymphoma Kinase (ALK) Rearrangement Treated by Brigatinib
Blood samples for Hematology, Blood samples for Chemistry, Blood sample for liver function tests - NSCLC
Phase 2RecruitingGroupe Francais De Pneumo-Cancerologie452025-06-192026-04-29
Clinical Trial to Evaluate the Efficacy and Safety of Codivir® in Addition to Standard Antiretroviral Treatment for HIV Infection in Antiretroviral-naïve Participants
ICF, Eligibility Assessment, Demographic data - HIV, HIV Infection
Phase 2RecruitingCode Pharma402023-07-202024-11-06
Baricitinib in the Treatment of New-onset Juvenile Dermatomyositis (MYOCIT)
Baricitinib, pharmacokinetics study, dosage of cytokines - Juvenile Dermatomyositis
Phase 2CompletedAssistance Publique - Hôpitaux de Paris162022-11-102026-04-23
Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19
Biochemistry blood test, Hematology blood test, D-Dimer test (coagulation) - Covid19, Corona Virus Infection
Phase 2CompletedMGC Pharmaceuticals d.o.o2402022-10-112023-03-15
Single Agent JNJ-56022473 in MDS and AML Patients FAILING HYPOMETHYLATING AGENT BASED THERAPY
JNJ-56022473, Bone marrow analyses and CBC with differential, Flow cytometry analyses - Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML)
Phase 2TerminatedGWT-TUD GmbH252016-07-012018-10-25

Conditions studied

Acquired Immunodeficiency Syndrome (1)  ·  COVID-19 (1)  ·  Coronavirus Infections (1)  ·  Dermatomyositis (1)  ·  HIV Infections (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Lung Neoplasms (1)  ·  Myelodysplastic Syndromes (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Code Pharma (1)  ·  GWT-TUD GmbH (1)  ·  Groupe Francais De Pneumo-Cancerologie (1)  ·  MGC Pharmaceuticals d.o.o (1)

Countries

France (3)  ·  Brazil (1)  ·  Germany (1)  ·  Israel (1)

Top investigators

Rita Nadaf (1)  ·  Uwe Platzbecker, Prof. (1)